Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results-Reference-Cited by-同舟云学术

Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results

Published:2018-01 Issue:1 Volume:73 Page:62-68
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Motzer Robert J.,Ravaud Alain,Patard Jean-Jacques,Pandha Hardev S.,George Daniel J.,Patel Anup,Chang Yen-Hwa,Escudier Bernard,Donskov Frede,Magheli Ahmed,Carteni Giacomo,Laguerre Brigitte,Tomczak Piotr,Breza Jan,Gerletti Paola,Lechuga Mariajose,Lin Xun,Casey Michelle,Serfass Lucile,Pantuck Allan J.,Staehler Michael

Publisher

Elsevier BV

Subject

Urology

Reference22 articles.

1. SEER cancer statistics factsheets: kidney and renal pelvis cancer;National Cancer Institute,2016

2. Adjuvant therapy in renal cell carcinoma-past, present, and future;Janowitz;Semin Oncol,2013

3. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease;Janzen;Urol Clin North Am,2003

4. Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy;Ravaud;N Engl J Med,2016

5. Improved prognostication of renal cell carcinoma using an integrated staging system;Zisman;J Clin Oncol,2001

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of a Nomogram for Predicting Postoperative Recurrence-Free Survival in Patients With Nonmetastatic Pathological T3a Stage Renal Cell Carcinoma;Clinical Genitourinary Cancer;2024-12

2. EVEREST: Attempting the Summit with Adjuvant Everolimus To Treat High-risk Renal Cell Carcinoma After Surgery;European Urology;2024-09

3. Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial;European Urology;2024-09

4. Contemporary Management of Renal Cell Carcinoma: A Review for General Practitioners in Oncology;Current Oncology;2024-08-22

5. Renal cell carcinoma;The Lancet;2024-08